Endonovo Therapeutics Company Description

Endonovo Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and distribution of non-invasive Electroceutical medical devices for regenerative medicine.

The company offers SofPulse, a non-invasive Electroceutical therapeutic device for the palliative treatment of soft tissue injuries, chronic wounds, and post-operative pain and edema.

Its Electroceuticals medical device is also used for the treatment of cardio chronic kidney disease, liver disease non-alcoholic steatohepatitis (NASH), cardiovascular, and peripheral artery disease (PAD) and ischemic stroke.

Endonovo Therapeutics, Inc. was founded in 2008 and is based in Woodland Hills, California.

Endonovo Therapeutics, Inc.

Country	United States
Founded	2008
Industry	Biotechnology
Sector	Healthcare
Employees	1
CEO	Alan Collier

Contact Details

Address: 6320 Canoga Avenue Woodland Hills, California 91367 United States
Phone	800 489 4774
Website	endonovo.com

Stock Details

Ticker Symbol	ENDV
Exchange	OTCMKTS
Stock Type	Common Stock
Fiscal Year	January - December
Reporting Currency	USD
ISIN Number	US29272H3003
SIC Code	2836

Key Executives

Name	Position
Alan Brian Collier	Chairman and Chief Executive Officer
Don Calabria	Vice President of Operations
Garry Michael Kann	Head of Corporate Development
Ira Weisberg	President and Chief Commercial Officer of Medical Division